Featured Session

Shifting from Campaigns to Continuous Engagement

The 1.3 trillion dollar biopharmaceutical industry is at a crossroads. The pandemic has done at least two things to our commercial model: first, it accelerated our shift to a sophisticated digital presence, and, second, it has changed message consumption preference of our health care professionals.

Frank Dolan and Hans Kaspersetz, Chief Innovation Officer at Relevate Health, explore what’s possible for life science brands.

There’s a window of opportunity for brands to rethink strategy, leverage data in new ways, and find themselves, at least their brands, standing in plain sight right where the customer needs them. Watch the session to learn how.

Speaker Spotlight

Hans Kaspersetz

Hans is a thought leader in life science brand strategy. Often quoted at industry conferences, Hans has been involved in numerous biopharma brands helping them through brilliant strategy and the latest technology to unlock brand potential.

Title
Chief Innovation Officer
Company
Event
Medicine to Market
Subscribe to our newsletter

Sign up to receive updates, promotions, and sneak peaks of upcoming event. Plus 20% off your next order.

Promotion nulla vitae elit libero a pharetra augue